During a press availability at the State Department, U.S. Secretary of State Marco Rubio sharply criticized Iran’s leaders.

As the guardian minister of Pune district, Maharashtra deputy chief minister Ajit Pawar was also seeking an upgrade to the Baramati airport.| India News ...

Northwestern Air Lease flight PLR732T, a BAe Jetstream 31, was conducting training at the Fort Smith airport (YSM), NT with two flight crew on board. After completing a VOR approach to runway 12, the ...

That all works great against expensive SAM radars that are mounted on trucks and put up on hills away from ground clutter. A GPS jammer randomly on a truck in an area even somewhat populated, for ...

Eastern Air Lines Flight 212 was flown by two cockpit crew members and attended to by two cabin attendants. Of the former, Captain James E. Reeves, 49, held type ratings on the Convair 240, 340, and ...

Vor Biopharma (VOR) rose ~17% on Tuesday after J.P. Morgan initiated its coverage with an Overweight recommendation and a Dec. 2026 price target of $43, citing a potential blockbuster status for the ...

Vor Biopharma Inc. (VOR) could be a solid choice for investors given its recent upgrade to a Zacks Rank #2 (Buy). An upward trend in earnings estimates -- one of the most powerful forces impacting ...

The pilot made a private flight between the La Môle-Saint-Tropez Airport and Paris-Le Bourget. At the end of a VOR approach for runway 25, he lined up on a disused runway located between runways 25 ...

Vor Biopharma Inc. (NASDAQ:VOR) on Tuesday priced an underwritten public offering of 10 million shares at $10.00 per share. The gross proceeds from the offering are expected to be $100 million. In ...

A psychologist argues that the sensation is not mysterious, but rather an emotion that scientists can detect. By Emma Goldberg There’s a type of awe that surrounds the Jewish High Holy Days that is ...

China biotech RemeGen and its new U.S. partner Vor Bio are on a roll with their first-in-class autoimmune treatment telitacicept. Two weeks after RemeGen revealed the success of a China phase 3 trial ...